Overview

Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment

Status:
Completed
Trial end date:
2018-03-26
Target enrollment:
Participant gender:
Summary
The purpose of the study is to improve the understanding of key patient reported outcomes such as quality of life as well as clinical outcomes in hemophilia A, in a global real world setting.
Details
Lead Sponsor:
Bayer
Treatments:
Factor VIII